The EMA ( European Medicines Agency ) is investigating findings by a group of independent academic researchers that suggest an...
Type 2 diabetes mellitus: individualised treatment targets for elderly patients using Vildagliptin add-on or lone therapy
Guidelines suggest setting individualised targets for glycaemic control in elderly patients with type 2 diabetes, despite no evidence.The aim of...
Diabetes mellitus: no new concerns for GLP-1 therapies identified on the basis of available evidence
The Committee for Medicinal Products for Human Use ( CHMP ) has finalised a review of GLP-1-based diabetes therapies. The...
Novartis has provided a safety update to European regulators of pooled data showing numerically less frequent liver enzyme elevations in...
Vildagliptin ( Galvus ), a new once-daily oral treatment option for type 2 diabetes, has demonstrated efficacy, especially in patients...
Research suggests that the investigational drug Vildagliptin ( Galvus ) improves the function of pancreatic islets in both animals and...
- Gad Anxiety
- Gallbladder Disease
- Gardenia Extract
- Gastric Adenocarcinoma
- Gastric Cancer
- Gastrointestinal Bleeding
- Gastrointestinal Stromal Tumor
- Gastro-Oesophageal Junction Adenocarcinoma
- Gaucher Disease